Dr. Sunil Kumar Aggarwal

AIMS Institute of Seattle
Co-Founder & Co-Director

Dr. Aggarwal is a Fellow of the American Academy of Physical Medicine and Rehabilitation, board-certified in Physical Medicine and Rehabilitation and Hospice and Palliative Medicine, and the Chair of the Integrative Medicine Special Interest Group at the American Academy of Hospice and Palliative Medicine. He is a Clinical Assistant Professor at the UW School of Medicine, an Affiliate Assistant Professor of Geography at UW, and a Faculty Member of the National Family Medicine Residency. Dr. Aggarwal is also an Associate Member of the New York Academy of Medicine and the Humboldt Institute for Interdisciplinary Marijuana Research. He is also currently an Associate Medical Director of MultiCare Hospice. He serves on the Editorial Advisory Board of the National Cancer Institute’s PDQ Cancer CAM information summary on cannabis. See more of Dr. Aggarwal’s work in his multiple fields of discipline at the links below.

Dr. Leanna Standish

AIMS Institute of Seattle
Co-Founder & Co-Director

Dr. Standish is a neuroscientist and physician living and working in Seattle WA.  She holds faculty appointments at the University of Washington School of Medicine in the Radiology Department as well as at Bastyr University.  She specializes in integrative oncology and neurology.  She leads cancer research teams and holds an FDA IND for a phase I clinical trial of ayahuasca, a psychoactive Amazonian tea.

Mary Brown
Cannabinoid Therapy Educator

SMJ Consulting

Mary Brown is dedicated to studying trends in data and patient responses to help guide medical professionals and patients towards developing a greater understanding of the beneficial impacts  of purposeful cannabinoid therapy dosing protocols. As founder of SMJ Consulting, she focuses on sharing her expertise through individual and group cannabis health education sessions, as well as acting in an advisory role to various cannabis companies on medicinal cannabis education. Mary is strongly invested in researching the impact of cannabinoids on pediatric cancer patients and believes deeply in advocating for the rights of patients of all ages to secure natural medicinal options.


Mary holds a Masters Degree in Educational Administration from WWU and has been focused on practical applications in cannabinoid therapy for over a decade. Driven by her desire for consumers to have access to the highest quality, most sustainable medications available, she has contributed intellectual property to cannabis formulations as well the development of delivery device technology with companies nationwide.

Follow Their Work